Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Biocad
- Target Recruit Count
- 48
- Registration Number
- NCT06715540
- Locations
- 🇷🇺
"Meditsinskiy teсhnologiy Maly", St. Petersburg, Russian Federation
An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients with Hemophilia B
- Conditions
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Biocad
- Target Recruit Count
- 24
- Registration Number
- NCT06700096
- Locations
- 🇷🇺
Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency", Kirov, Russia, Russian Federation
🇷🇺Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders), Moscow, Russia, Russian Federation
🇷🇺Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia), Moscow, Russia, Russian Federation
An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients with Relapsed/Refractory Multiple Myeloma
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Biocad
- Target Recruit Count
- 100
- Registration Number
- NCT06668792
- Locations
- 🇷🇺
State budgetary healthcare institution of the Sverdlovsk region "Sverdlovsk regional clinical hospital №1", Ekaterinburg, Russian Federation
🇷🇺SBHI of the Kaliningrad region "Central City Clinical Hospital", Kaliningrad, Russian Federation
🇷🇺SAHI "Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigala", Kazan, Russian Federation
Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children with Moderate to Severe Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2024-10-14
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Biocad
- Target Recruit Count
- 140
- Registration Number
- NCT06640517
- Locations
- 🇷🇺
Federal State Budgetary Educational Institution of Higher Education "Altai State Medical University" of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation
🇷🇺State budgetary healthcare institution "Chelyabinsk Regional Clinical Dermatovenerological Dispensary", Chelyabinsk, Russian Federation
🇷🇺State budgetary institution of the Sverdlovsk region "Ural Research Institute of Dermatovenereology and Immunopathology", Ekaterinburg, Russian Federation
Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® As Monotherapy in Subjects with Advanced Melanoma of the Skin
- First Posted Date
- 2024-10-14
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Biocad
- Target Recruit Count
- 392
- Registration Number
- NCT06640530
- Locations
- 🇧🇾
Healthcare Institution "Brest Regional Oncological Dispensary", Brest, Belarus
🇧🇾Health Institution "Gomel Regional Clinical Oncology Center", Gomel, Belarus
🇧🇾Healthcare Institution "Minsk City Clinical Cancer Center", Minsk, Belarus
Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)
- Conditions
- Interventions
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Biocad
- Target Recruit Count
- 421
- Registration Number
- NCT06333210
- Locations
- 🇷🇺
Chelyabinsk Regional Clinical hospital, Chelyabinsk, Russian Federation
🇧🇾1St City Clinical Hospital, Minsk, Minsk, Belarus
🇷🇺Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Kazan, Russian Federation
A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Biocad
- Target Recruit Count
- 252
- Registration Number
- NCT06296121
- Locations
- 🇷🇺
Russian Research Institute of Hematology and Transfusiology of the Federal Medical and Biological Agency, Saint Petersburg, Russian Federation
🇷🇺Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russian Federation
🇷🇺Kuzbass Regional Clinical Hospital named after S.V. Belyaev, Kemerovo, Russian Federation
A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
- Conditions
- Interventions
- First Posted Date
- 2023-12-29
- Last Posted Date
- 2023-12-29
- Lead Sponsor
- Biocad
- Target Recruit Count
- 50
- Registration Number
- NCT06185335
- Locations
- 🇷🇺
State Autonomous Institution for Healthcare of Sverdlovsk region "Sverdlovsk Regional Clinical Hospital №1", Ekaterinburg, Russian Federation
🇷🇺State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation
🇷🇺State Autonomous Institution for Healthcare "Chelyabinsk Regional Clinical Hospital", Chelyabinsk, Russian Federation
Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)
- Conditions
- Interventions
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Biocad
- Target Recruit Count
- 28
- Registration Number
- NCT06120582
- Locations
- 🇧🇾
Republican Scientific and Practical Center for Radiation Medicine and Human Ecology, Gomel, Belarus
🇷🇺Federal Budgetary Institution "Moscow City Clinical Hospital named after S. P. Botkin", Moscow, Russian Federation
🇷🇺LLC "Medis", Nizhny Novgorod, Russian Federation
A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- Biocad
- Target Recruit Count
- 300
- Registration Number
- NCT06112808
- Locations
- 🇷🇺
Regional State Budgetary of Healthcare Insti-tution "Kostroma Clinical Oncology Dispensary", Kostroma, Russian Federation
🇷🇺LLC "New Clinic", Pyatigorsk, Stavropol Krai, Russian Federation
🇷🇺"Saint Petersburg Clinical Research and Practice Center for Specialized Medical Care (Oncology)", Saint Petersburg, Russian Federation